Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target.

MLA

Alvisi, Giorgia, et al. “Multimodal Single-Cell Profiling of Intrahepatic Cholangiocarcinoma Defines Hyperactivated Tregs as a Potential Therapeutic Target.” Journal of Hepatology, vol. 77, no. 5, Nov. 2022, pp. 1359–72. EBSCOhost, https://doi.org/10.1016/j.jhep.2022.05.043.

APA

Alvisi, G., Termanini, A., Soldani, C., Portale, F., Carriero, R., Pilipow, K., Costa, G., Polidoro, M., Franceschini, B., Malenica, I., Puccio, S., Lise, V., Galletti, G., Zanon, V., Colombo, F. S., De Simone, G., Tufano, M., Aghemo, A., Di Tommaso, L., … Lleo, A. (2022). Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target. Journal of Hepatology, 77(5), 1359–1372. https://doi.org/10.1016/j.jhep.2022.05.043

Chicago

Alvisi, Giorgia, Alberto Termanini, Cristiana Soldani, Federica Portale, Roberta Carriero, Karolina Pilipow, Guido Costa, et al. 2022. “Multimodal Single-Cell Profiling of Intrahepatic Cholangiocarcinoma Defines Hyperactivated Tregs as a Potential Therapeutic Target.” Journal of Hepatology 77 (5): 1359–72. doi:10.1016/j.jhep.2022.05.043.